A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA)

被引：0

作者：

Powles, T. B. ^{[1
]}

van der Heijden, M. S. ^{[2
]}

Galsky, M. D. ^{[3
]}

Al-Ahmadie, H. ^{[4
]}

Meeks, J. J. ^{[5
]}

Nishiyama, H. ^{[6
]}

Vu, T. Q. ^{[7
]}

Antonuzzo, L. ^{[8
]}

Wiechno, P. ^{[9
]}

Atduev, V. ^{[10
]}

Kann, A. G. ^{[11
]}

Kim, T-H. ^{[12
]}

Rodriguez, C. Suarez ^{[13
]}

Chang, C-H. ^{[14
,15
]}

Roghmann, F. ^{[16
]}

Ozguroglu, M. ^{[17
]}

Armstrong, J. ^{[18
]}

Ho, S. ^{[19
]}

Hois, S. ^{[19
]}

Catto, J. ^{[20
,21
]}

机构：

[1] Queen Mary Univ London, Barts Canc Inst, Genitourinary Oncol, London, England

[2] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands

[3] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY USA

[4] Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, New York, NY USA

[5] Northwestern Univ, Feinberg Sch Med, Dept Urol Biochem & Mol Genet, Chicago, IL USA

[6] Univ Tsukuba, Dept Urol, Tsukuba, Ibaraki, Japan

[7] Vietnam Natl Canc Hosp, Dept Internal Med 3, Hanoi, Vietnam

[8] Univ Careggi, Azienda Osped, SODc Oncol Med, Florence, Italy

[9] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Urooncol, Warsaw, Poland

[10] Fed Med Biol Agcy, Volga Dist Med Ctr, Nizhnii Novgorod, Russia

[11] Hosp Alemao Oswaldo Cruz, Oncol Clin, Sao Paulo, Brazil

[12] Kyungpook Natl Univ, Sch Med, Dept Urol, Daegu, South Korea

[13] Hosp Univ Vall Hebron, Vall Hebron Inst Oncol VHIO, Med Oncol, Vall Hebron Barcelona Hosp Campus, Barcelona, Spain

[14] China Med Univ & Hosp, Dept Urol, Taichung, Taiwan

[15] China Med Univ & Hosp, Sch Med, Taichung, Taiwan

[16] Ruhr Univ Bochum, Marien Hosp, Univ Hosp, Dept Urol, Herne, Germany

[17] Istanbul Univ Cerrahpasa, Cerrahpasa Med Sch, Dept Internal Med, Istanbul, Turkey

[18] AstraZeneca, Stat, Cambridge, England

[19] AstraZeneca, Oncol, Gaithersburg, MD USA

[20] Univ Sheffield, Sch Med & Populat Hlth, Div Clin Med, Sheffield, S Yorkshire, England

[21] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.08.2327

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA5

引用

页码：1271 / 1271

页数：1

共 50 条

[41] RADICAL CYSTECTOMY AND ADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER IN THE ELDERLY: A POPULATION-BASED STUDY
Leveridge, Michael
Siemens, Robert
Mackillop, William
Peng, Yingwei
Berman, David
Booth, Christopher
JOURNAL OF UROLOGY, 2014, 191 (04): : E25 - E25
[42] The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy
Hiromi Murasawa
Takuya Koie
Chikara Ohyama
Hayato Yamamoto
Atsushi Imai
Shingo Hatakeyama
Takahiro Yoneyama
Yasuhiro Hashimoto
Ikuya Iwabuchi
Masaru Ogasawara
Toshiaki Kawaguchi
International Journal of Clinical Oncology, 2017, 22 : 159 - 165
[43] Retrospective Analysis of the Efficacy of Two Cycles of M-VAC Neoadjuvant Chemotherapy Followed by Radical Cystectomy for Muscle-invasive Bladder Cancer
Kitagawa, Yasuhide
Izumi, Komi
Miwa, Sotaro
Kadono, Yoshifumi
Konaka, Hiroyuki
Mizokami, Atsushi
Namiki, Mikio
ANTICANCER RESEARCH, 2013, 33 (10) : 4497 - 4503
[44] Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients
Fujiwara, Motohiro
Tanaka, Hajime
Kobayashi, Masaki
Nakamura, Yuki
Fan, Bo
Ishikawa, Yudai
Fukuda, Shohei
Toda, Kazuma
Yoshida, Soichiro
Yokoyama, Minato
Yoshimura, Ryoichi
Fujii, Yasuhisa
CLINICAL GENITOURINARY CANCER, 2024, 22 (02) : 193 - 200.e1
[45] Adjuvant Treatment of Residual Disease Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle Invasive Bladder Cancer
Krebs, Markus
Sokolakis, Ioannis
Seiler, Roland
Daneshmand, Siamak
Grivas, Petros
Gakis, Georgios
BLADDER CANCER, 2020, 6 (04) : 525 - 535
[46] A phase Ⅱ study of neoadjuvant chemotherapy followed by organ preservation in patients with muscle-invasive bladder cancer
Chinna Babu Dracham
Narendra Kumar
Santosh Kumar
Arun Elangovan
Budhi Singh Yadav
Ravimohan SMavuduru
Anupam Lal
Pramod KGupta
Rakesh Kapoor
Asian Journal of Urology, 2022, (03) : 318 - 328
[47] Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
Elsayed, Dalia Hamouda
Elfarargy, Ola M.
Elderey, Mohamed Salah
Mandour, Doaa
Atef, Nora
Hemeda, Rehab
Kamel, Mostafa
Azony, Ahmed
Taha, Heba F.
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2023, 27 (01): : 1 - 9
[48] Neoadjuvant Therapy Schemes combined with adjuvant Therapy for muscle-invasive Bladder Cancer before or after radical Cystectomy
Rexer, H.
Grimm, M-O.
Retz, M.
AKTUELLE UROLOGIE, 2021, 52 (05) : 428 - 429
[49] NEMIO: A randomized phase II trial evaluating efficacy and safety of dose dense MVAC (ddMVAC) plus durvalumab plus /- tremelimumab as neoadjuvant treatment in patients with bladder muscle-invasive urothelial carcinoma
Thibault, C.
Audenet, F.
Borchiellini, D.
Huillard, O.
Barthelemy, P.
Pouessel, D.
Flechon, A.
Blons, H.
Sautes-Fridman, C.
Sun, C-M.
Verkarre, V.
Pallet, N.
Mejean, A.
Rouabah, M.
Helali, I.
Elaidi, R-T.
Oudard, S.
ANNALS OF ONCOLOGY, 2019, 30
[50] Delays in radical cystectomy for muscle-invasive bladder cancer
Chu, Alice T.
Holt, Sarah K.
Wright, Jonathan L.
Ramos, Jorge D.
Grivas, Petros
Yu, Evan Y.
Gore, John L.
CANCER, 2019, 125 (12) : 2011 - 2017

← 1 2 3 4 5 →